The digital revolution: technological innovations to enable automation in cell therapy manufacturing

Cell & Gene Therapy Insights 2022; 8(6), 661;

DOI: 10.18609/cgti.2022.099

Published: 13 July 2022
Poster
Bruce Greenwald, Sean Chang, Krish Roy

The manufacturing process is complex, labor-intensive, and requires many open manipulations. It is also difficult to synchronize different instruments and products to make the workflow traceable and compliant with regulatory requirements. To solve these issues, a closed modular system can help minimize contamination and maintain flexibility. Most importantly, automating the process can reduce labor and human error. It is in this third aspect that digitalization plays a particularly vital role.


You can view or download the poster here.

If you are interested in learning more, you can read the full discussion or watch to the webinar here.



To find out more, you can read the full article here.